#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchopulmonary dysplasia Myxoid liposarcoma Oesophageal adenocarcinoma Gastrointestinal stromal tumour Facioscapulohumeral muscular dystrophy Conjunctivitis allergic Acute lymphocytic leukaemia recurrent Immunodeficiency common variable Hypocalcaemia Neuroendocrine carcinoma Hodgkin's disease recurrent Neuroendocrine carcinoma metastatic Mucous membrane pemphigoid Hepatoblastoma Deafness bilateral More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia – Diagnostics Waldenstrom’s macroglobulinaemia recurrent – Basic Information Familial haemophagocytic lymphohistiocytosis – Life with Disease Uterine leiomyosarcoma – Treatment Arterial tortuosity syndrome – Life with Disease Hairy cell leukaemia recurrent Glomerulonephritis rapidly progressive – Treatment Toxic epidermal necrolysis – Treatment Toxic epidermal necrolysis – Life with Disease Hyperoxaluria – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iobitridol Iohexol Romosozumab Metolazone BROLUCIZUMAB Dutasteride Levofloxacin Sacubitril Valsartan Arrhenatherum Elatius Vb10.16 Riliprubart GSKVX000000034792 Aon-D21 A52 Goserelin Seladelpar Oseltamivir Mbf-015 FERUMOXTRAN-10 Remifentanil Hydrochloride More therapies…

    Learn about Your Condition

    Myotonia Actinic cheilitis Herpes simplex reactivation Kaposi's sarcoma Monogenic diabetes Colitis Breast cancer Albright's disease Cholangitis sclerosing Epstein-Barr virus infection Angina pectoris Pulmonary tuberculosis Thermal burn Pigmentary glaucoma Pulmonary vascular disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study comparing injection under the skin versus infusion into the vein of tislelizumab with chemotherapy for patients with advanced gastric or gastroesophageal junction cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Tislelizumab
    Austria Czechia France Italy Poland Spain

  • Comparing magnesium sulfate and dexmedetomidine combined with ropivacaine for pain relief after breast cancer surgery in women undergoing mastectomy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Magnesium Sulfate
    • Ropivacaine Hydrochloride
    • Dexmedetomidine
    Spain

  • Testing the Safety and Effects of TUB-030 in Patients with Advanced Head and Neck Cancer or Non-Small-Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    • Non-small cell lung cancer
    Investigated Drugs:
    • TUB-030
    France Romania Spain

  • A Study of Botulinum Toxin Type A for Preparing the Abdominal Wall Before Surgery in Patients with Large Complex Hernias

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hernia repair
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    Italy

  • Study of RSV vaccine and nirsevimab combination to prevent RSV infection in infants up to 12 months of age

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Belgium The Netherlands

  • A Study of BMS-986517 for Adults with Advanced Solid Tumors to Test Safety and Find the Best Dose

    Recruiting

    2 1 1
    Denmark Spain
Previous Page
1 … 109 110 111 112 113 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!